Does Tranexamic Acid Reduce Blood Transfusion Cost for Primary Total Hip Arthroplasty? A Case-Control Study

被引：24

作者：

Harris, Ryan N. ^{[1
]}

Moskal, Joseph T. ^{[1
,2
]}

Capps, Susan G. ^{[3
]}

机构：

[1] Virginia Tech Caril Sch Med, Roanoke, VA USA

[2] Virginia Tech Caril Sch Med, Caril Clin, Roanoke, VA USA

[3] BENSOL, Warsaw, IN 46582 USA

来源：

JOURNAL OF ARTHROPLASTY | 2015年 / 30卷 / 02期

关键词：

hip arthroplasty; tranexamic acid; transfusion; cost;

D O I：

10.1016/j.arth.2014.08.020

中图分类号：

R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学（修复外科学）];

学科分类号：

摘要：

Peri-operative tranexamic acid (TXA) significantly reduces the need for allogeneic blood transfusion in total hip arthroplasty (THA) and thus hospital costs are reduced. Before employing TXA in primary THA at our institution, facility costs were $286.90/THA for blood transfusion and required 0.45 man-hours/THA (transfusion rate 19.87%). After incorporating TXA, the cost for intravenous application was $ 123.38/THA for blood transfusion and TXA medication and 0.07 man-hours/THA (transfusion rate 4.39%) and the cost for topical application was $132.41/THA for blood transfusion and TXA and 0.14 man-hours/THA (transfusion rate 12.86%). TXA has the potential to reduce the facility cost per THA and the man-hours/THA from blood transfusions. (C) 2014 Elsevier Inc. All rights reserved.

引用

页码：192 / 195

页数：4

共 12 条

[1]

Alshryda S, 2014, J ORTHOP TRAUMATOL

[2] Topical (Intra-Articular) Tranexamic Acid Reduces Blood Loss and Transfusion Rates Following Total Hip Replacement A Randomized Controlled Trial (TRANX-H) [J].